VSP Formulary Updates for Stellest Lenses—November 2026
Effective November 3, 2026, VSP is updating its ophthalmic product formulary to expand access to proven myopia management solutions authorized and cleared by the FDA, beginning with the addition of Essilor Stellest lenses.
Action Required: The formulary updates will be added to your system automatically. However, if your practice dispenses Stellest lenses, it’s important that you do the following once the new lenses are available November 3:
-
Deactivate and discontinue use of the Stellest lens without the inherent coating and be sure any orders with that lens have been invoiced.
-
Activate and price the new lenses being added to the formulary with the inherent coating and consider how the updates might impact your existing pricing.
To locate the lenses, select Stellest from the Style drop-down list in the Eyeglass Lens Setup Quick Setup. See Setting Up Eyeglass Lenses Using the Quick Setup for instructions.
You can find information about the specific changes in the Product Index and the Lens Enhancement Charts located in the Provider Reference Manual on VSPOnline at eyefinity.com, in November 2026.
If you have questions about the formulary changes, contact your VSP representative or email providernetworkdevelopment@vsp.com. For software-related questions, contact Eyefinity Customer Care at epmsupport@eyefinity.com.